MedTrace Logo

Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy

NCT02085876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2014-03-13

No results posted yet for this study

Summary

This is a single centre prospective open-label, non-randomised pilot study whose aim is to identify MRI parameters to better evaluate inflammation and liver fibrosis and thus, in the near future, to avoid the need for liver biopsy.

To achieve this:

* The MRI study will be completed by adding two sequences: Measurement of T1 and multiecho T2\*. The other data will be extracted from usual sequences.
* Part of the histological samples will be used for the weighted levels of fat and iron, and for the lipidomic study.
* Usual blood samples will be completed by samples for the serum library

Conditions

Interventions

OTHER

2 additional MRI sequences

OTHER

An additional blood sample

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2016-02-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02085876 on ClinicalTrials.gov